Pulmonary Alveolar Proteinosis in Children: An Update on Pathogenesis, Clinical Features and Review of Literature

Journal Title: Journal Of Pediatric Critical Care - Year 2016, Vol 3, Issue 3

Abstract

Pulmonary alveolar Proteinosis (PAP) is a rare disease whereby the alveolar sacs are filled with a lipoproteinaceous material. The accumulation of this material hinders gas exchange, resulting in a variety of presentations involving all age groups. Symptoms range in severity from mild cough and dyspnea in most patients, to respiratory distress and failure to thrive in infants and young children. Depending on the etiology, PAP cases are classified as being hereditary, secondary, or autoimmune. Despite the different mechanisms underlying these, a unifying pathophysiological concept for PAP exists. Diagnosis is often difficult, and takes time to establish, given the vague nature of the presenting symptoms of this disease. High resolution computed tomography (HRCT) remains the preferred radiological diagnostic tool. Diagnosis is confirmed by lung biopsy and bronchoalveolar fluid lavage. Management encompasses whole lung lavage (WLL), exogenous GM-CSF therapy, supportive respiratory measures where necessary, and even lung transplant in some severe cases. Children affected with PAP remain a population with high mortality. Pediatric literature is scarce in comparison to PAP described in adults. This paper focuses on reviewing the pathophysiology in context to recent advances in molecular genetics, diagnosis, and management in children with this disease.

Authors and Affiliations

Ahmad Hamed, Daniel Rosenbaum, Esther Cheng, Rizwana Popatia, Weill Cornell

Keywords

Related Articles

Pattern of drug prescription in the pediatric intensive care unit of a tertiary care hospital with emphasis on antimicrobial utilization

Various therapeutic classes of drugs are used in children admitted to a pediatric intensive care unit (PICU) and among them antimicrobials are the most frequently prescribed agents. However, not infrequently, antimicrobi...

Spine and Spinal Cord Injury in Children

Trauma to the spine can cause injuries involving spinal cord, vertebra or both. Although less frequent compared to adults, Traumatic Spinal Cord Injury (TSCI) in the pediatric population is not rare and has high morbidit...

Clinical Management of Diabetic Ketoacidosis

Diabetic Ketoacidosis (DKA) is a commonly seen condition in Pediatric age group requiring admission to the PICU. The scope of this article is to discuss the management of children with moderate to severe DKA requiring ho...

Functional outcomes in Children with Severe Sepsis – A Prospective Observational Study

To evaluate functional outcomes in children with severe sepsis and septic shock admitted to the PICU using Pediatric Overall Performance Category Scale (POPC) and Pediatric Cerebral Performance Category (PCPC) scales at...

External Jugular Venous Access in Children : A low cost and feasible route for Emergency Fluid Resuscitation and Inotropic Therapy in Resource Poor Clinical Settings ?

Introduction: The External Jugular Vein is superficial with a wide caliber and is also isolated from major neurovascular structures in neck. It can be simply cannulated and used for fluid and inotrope administration with...

Download PDF file
  • EP ID EP339345
  • DOI 10.21304/2016.0303.00125
  • Views 90
  • Downloads 0

How To Cite

Ahmad Hamed, Daniel Rosenbaum, Esther Cheng, Rizwana Popatia, Weill Cornell (2016). Pulmonary Alveolar Proteinosis in Children: An Update on Pathogenesis, Clinical Features and Review of Literature. Journal Of Pediatric Critical Care, 3(3), 22-32. https://europub.co.uk/articles/-A-339345